Abstract
Peripheral artery disease (PAD) is characterized by the narrowing of arteries of the extremities. Currently, it affects between 8–12 million Americans and over 200 million people worldwide, and has emerged as a significant global public health concern [1]. The burden of this disease is partly due to the rise in epidemics of diabetes, renal insufficiency, and an aging population, all of which increase the risk of developing vascular disease [2, 3, 4]. The clinical presentation of PAD is broad, ranging from being asymptomatic, increased severity to intermittent claudication with activity, and, at its worst, critical limb ischemia (CLI), which is characterized by rest pain and/or non-healing ulcers. CLI patients often face the morbid prospect of limb amputation due to a non-healing ulceration. Not only do these patients face the prospect of losing their limb but with this they lose their independence and may even lose their life. Patients undergoing amputation have a mortality of 50% at 5 years and 70% at 10 years [5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, Tasc II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1):S1–S75.
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg. 2008;48(3):619–26.
Bishop PD, Feiten LE, Ouriel K, Nassoiy SP, Pavkov ML, Clair DG, Kashyap VS. Arterial calcification increases in distal arteries in patients with peripheral arterial disease. Ann Vasc Surg. 2008;22(6):799–805.
Mustapha JA, Diaz-Sandoval LJ, Karenko B, Saab F. Atherectomy and critical limb ischemia: a treatment approach for severely calcified vessels. Vascular Disease Management. 2013;10(10):E198–207.
Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86(1):64–70.
Suri R, Wholey MH, Postoak D, Hagino RT, Toursarkissian B. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv. 2006;67(3):417–22.
Adams GL, Khanna PK, Staniloae CS, Abraham JP, Sparrow EM. Optimal techniques with the diamondback 360 system achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res. 2011;4(2):220–9.
Adams GL, Das T, Lee MS, Beasley R, Mustapha J. Subanalysis of the CONFIRM registries: acute procedural outcomes in Claudicant and critical limb ischemia patients with varying levels of calcification treated for peripheral arterial disease with orbital Atherectomy. J Invasive Cardiol. 2015;27(11):516–20.
Lee MS, Mustapha J, Beasley R, Chopra P, Das T, Adams GL. Impact of lesion location on procedural and acute angiographic outcomes in patients with critical limb ischemia treated for peripheral artery disease with orbital atherectomy: a CONFIRM registries subanalysis. Catheter Cardiovasc Interv. 2015;87(3):440–5.
Lee MS, Beasley R, Adams GL. Impact of advanced age on procedural and acute angiographic outcomes in patients treated for peripheral artery disease with orbital Atherectomy: a CONFIRM registries subanalysis. J Invasive Cardiol. 2015;27(8):381–6.
Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26(8):355–60.
Staniloae CS, Korabathina R. Orbital atherectomy: device evolution and clinical data. J Invasive Cardiol. 2014;26(5):215–9.
Safian RD, Niazi K, Runyon JP, Dulas D, Weinstock B, Ramaiah V, Heuser R. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv. 2009;73(3):406–12.
Shammas NW, Lam R, Mustapha J, Ellichman J, Aggarwala G, Rivera E, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther. 2012;19(4):480–8.
Das T, Mustapha J, Indes J, Vorhies R, Beasley R, Doshi N, Adams GL. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities. Catheter Cardiovasc Interv. 2014;83(1):115–22.
Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol. 2014;37(4):898–907.
Tepe G, Beschorner U, Ruether C, Fischer I, Pfaffinger P, Noory E, Zeller T. Drug-eluting balloon therapy for Femoropopliteal occlusive disease predictors of outcome with a special emphasis on calcium. J Endovasc Ther. 2015;22(5):727–33.
Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN. PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64(15):1568–76.
Adams GL, Mustapha J, Gray W, Hargus NJ, Martinsen BJ, Ansel G, Jaff MR. The LIBERTY study: design of a prospective, observational, multicenter trial to evaluate the acute and long-term clinical and economic outcomes of real-world endovascular device interventions in treating peripheral artery disease. Am Heart J. 2016 Apr;174:14–21. https://doi.org/10.1016/j.ahj.2015.12.013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Subramanian, V., Smith, I., Adams, G.L. (2018). Peripheral Artery Orbital Atherectomy: Principles and Clinical Applications. In: Lanzer, P. (eds) Textbook of Catheter-Based Cardiovascular Interventions. Springer, Cham. https://doi.org/10.1007/978-3-319-55994-0_80
Download citation
DOI: https://doi.org/10.1007/978-3-319-55994-0_80
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55993-3
Online ISBN: 978-3-319-55994-0
eBook Packages: MedicineMedicine (R0)